Mettler-Toledo International Inc.
NYSE:MTDMedical - Diagnostics & Research
+$16.60 today
- Market cap
- $34.55B
- Beta
- 1.26
- P/E (TTM)
- 26.6
- EPS (TTM)
- $43.14
Volume 0.16M
Average 0.19M
MTD Income Tax Expense
Income taxes recognized for the period, including current and deferred tax.
Mettler-Toledo International Inc.NYSE: MTD
Income Tax Expense · Q2 FY2026 · quarter ended Jun 2026
Income tax expense growth accelerates
Q2 FY2026 income tax expense of $56.5M rose 22.0% year over year, ahead of the -1.3% change in trailing-twelve-month income tax expense. Sequentially, it rose 40.5% from the prior quarter. Over 3 fiscal years it compounded at -3.2% a year.
Context
- Income tax expense amounted to 4.5% of revenue in FY2025, unchanged from a year earlier.
- Income tax expense increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +22.0% holds above the trailing-twelve-month pace of -1.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Income Tax Expense history
USD · from the income statement
- Latest · FY2025
- 179.72M USD
- Year-over-year change
- +3.2%
- 4-year CAGR
- -0.1%
| Period | Period end | Income Tax Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 179.72M | +3.2% |
| FY2024 | 2024-12-31 | 174.08M | -5.9% |
| FY2023 | 2023-12-31 | 184.95M | -6.6% |
| FY2022 | 2022-12-31 | 198.09M | +9.8% |
| FY2021 | 2021-12-31 | 180.38M | — |
Income Tax Expense vs competitors
How MTD compares with its peers on the latest reported figures
- MTD's LTM Jun 2026 income tax expense of $191.76M is the 5th highest of the 10 companies compared; the peer median is $162M.
- Its year-over-year change of -1.3% is the 6th highest of 10, against a peer median of +7.6%.
- Income tax expense amounts to 4.6% of revenue for MTD, versus a peer median of 1.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $742M | +36.4% | -8.0% | 1.6% | |
| LTM Sep 2026 | $487M | -27.5% | -8.9% | 1.9% | |
| LTM Sep 2026 | $241.1M | +34.2% | +18.6% | 3.7% | |
| LTM Jul 2026 | $218M | +25.3% | -19.2% | 3.0% | |
| LTM Jun 2026 | $191.76M | -1.3% | -3.2% | 4.6% | |
| LTM Jun 2026 | $162M | +23.3% | -2.7% | 4.5% | |
| LTM Jun 2026 | $40.4M | -33.9% | -36.9% | 1.2% | |
| LTM Jul 2026 | $39.16M | -69.8% | -4.8% | 0.8% | |
| LTM Jul 2026 | $20.81M | -44.2% | -43.0% | 0.7% | |
| LTM Oct 2026 | $17.15M | +7.6% | +6.5% | 1.6% | |
| Peer median (excluding MTD) | $162M | +7.6% | -8.0% | 1.6% | |
Competitors are the stored peer set for MTD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.72B | 3.92B | 3.79B | 3.87B | 4.03B |
| Cost of Revenue | 1.61B | 1.68B | 1.62B | 1.62B | 1.64B |
| Gross Profit | 2.11B | 2.24B | 2.17B | 2.25B | 2.39B |
| Gross Margin | 56.7% | 57.2% | 57.3% | 58.2% | 59.4% |
| Research & Development | 169.77M | 177.12M | 185.28M | 189.36M | 199.37M |
| Selling, General & Admin | 943.98M | 938.46M | 904.11M | 936.3M | 998.31M |
| Operating Expenses | 1.11B | 1.12B | 1.09B | 1.13B | 1.27B |
| Depreciation & Amortization | 108.06M | 113.02M | 121.16M | 123.22M | 125.61M |
| EBITDA | 1.1B | 1.24B | 1.2B | 1.25B | 1.24B |
| EBITDA Margin | 29.7% | 31.6% | 31.7% | 32.3% | 30.9% |
| Operating Income | 994.74M | 1.13B | 1.08B | 1.13B | 1.12B |
| Operating Margin | 26.8% | 28.7% | 28.5% | 29.1% | 27.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 43.24M | 55.39M | 77.37M | 74.63M | 68.52M |
| Other Income / Expenses | (45.38M) | (55.63M) | (105.96M) | (89.83M) | (69.58M) |
| Income Before Tax | 949.36M | 1.07B | 973.73M | 1.04B | 1.05B |
| Pre-Tax Margin | 25.5% | 27.3% | 25.7% | 26.8% | 26.1% |
| Income Tax Expense | 180.38M | 198.09M | 184.95M | 174.08M | 179.72M |
| Net Income | 768.99M | 872.5M | 788.78M | 863.14M | 869.19M |
| Net Margin | 20.7% | 22.3% | 20.8% | 22.3% | 21.6% |
| EPS (Basic) | 33.25 | 38.79 | 36.10 | 40.67 | 42.17 |
| EPS (Diluted) | 32.78 | 38.41 | 35.90 | 40.48 | 42.05 |
| Weighted Avg Shares | 23.13M | 22.49M | 21.85M | 21.22M | 20.61M |
| Weighted Avg Shares (Diluted) | 23.46M | 22.72M | 21.97M | 21.32M | 20.67M |
Mettler-Toledo International Inc.
NYSE:MTD
Intrinsic Alpha fair value
Locked
Current Price
$1,737.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.